Evotec SE (EVO) Non-Current Deferred Tax Liability (2009 - 2026)
Evotec SE's (EVO) quarterly Non-Current Deferred Tax Liability came in at $11.9 million in Q2 2026, down 23.06% year-over-year from $15.5 million in Q2 2025, and down 19.52% quarter-over-quarter from $14.8 million in Q1 2026.
Analysis
Evotec SE (EVO) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Non-Current Deferred Tax Liability across 9 years of filings, most recently posting $11.9 million for Q2 2026.
- In Q2 2026, Non-Current Deferred Tax Liability fell 23.06% year-over-year to $11.9 million; the TTM figure through Jun 2026 stood at $11.9 million (down 23.06% YoY), while the FY2025 annual figure was $16.6 million, up 5.96% from the prior year.
- Non-Current Deferred Tax Liability came in at $11.9 million for Q2 2026 at Evotec SE, down from $14.8 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $20.8 million in Q2 2023 to a low of $11.9 million in Q2 2026.
- Average Non-Current Deferred Tax Liability over 5 years is $16.7 million, with a median of $15.9 million recorded in 2025.
- Year-over-year, Non-Current Deferred Tax Liability fell 23.53% in 2022 and grew 10.58% in 2025.
- Over 5 years, Non-Current Deferred Tax Liability stood at $18.9 million in 2022, then climbed by 3.26% to $19.5 million in 2023, then declined by 20.51% to $15.5 million in 2024, then climbed by 10.58% to $17.2 million in 2025, then sank by 30.41% to $11.9 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $11.9 million in Q2 2026, $14.8 million in Q1 2026, and $17.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.94 Mn |
| Mar 31, 2026 | 14.83 Mn |
| Dec 31, 2025 | 17.15 Mn |
| Sep 30, 2025 | 15.95 Mn |
| Jun 30, 2025 | 15.51 Mn |
| Mar 31, 2025 | 14.24 Mn |
| Dec 31, 2024 | 15.51 Mn |
| Sep 30, 2024 | 15.43 Mn |
| Dec 31, 2023 | 19.51 Mn |
| Jun 30, 2023 | 20.83 Mn |
| Dec 31, 2022 | 18.90 Mn |
| Sep 30, 2022 | 17.32 Mn |
| Mar 31, 2022 | 19.70 Mn |
| Dec 31, 2021 | 20.23 Mn |
| Sep 30, 2021 | 22.65 Mn |
| Dec 31, 2020 | 24.32 Mn |
| Sep 30, 2010 | 8.50 Mn |
| Jun 30, 2010 | 3.19 Mn |
| Mar 31, 2010 | 2,539.56 |
| Dec 31, 2009 | 2.92 Mn |